Literature DB >> 19861078

Rhombencephalitis and coxsackievirus A16.

Kazuna Goto, Masafumi Sanefuji, Koichi Kusuhara, Yorihiro Nishimura, Hiroyuki Shimizu, Ryutaro Kira, Hiroyuki Torisu, Toshiro Hara.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19861078      PMCID: PMC2866411          DOI: 10.3201/eid1510.090594

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Hand, foot, and mouth disease (HFMD) is a common illness in children and is mainly caused by coxsackievirus A16 (CA16) and enterovirus 71 (EV71). Although its clinical course is usually uneventful and most patients experience a full recovery, serious neurologic complications, including encephalitis, can occur secondarily to HFMD caused by EV71. Such neurological complications occurred during an epidemic in Taiwan in 1998 (). Encephalitis caused by EV71 is characterized by rhombencephalitis, which is a combination of brainstem encephalitis and cerebellitis. Signs and symptoms of rhombencephalitis are irritability, myoclonus, ataxia, and cranial nerve involvement (). In contrast to EV71, HFMD caused by CA16 is associated with few neurologic complications with the exception of infrequent aseptic meningitis (). We report a case of rhombencephalitis that developed in an infant as a complication of HFMD caused by CA16. HFMD was diagnosed in a 23-month-old girl on the basis of high fever (>40°C, 3 d duration), stomatitis, and multiple papules on her palms, soles, and buttocks. Her illness occurred in the summer of 2007, when sentinel surveillance in the region indicated an epidemic of HFMD caused by both CA16 and EV71. She was admitted to our hospital in Fukoka, Japan, on day 4 of illness because of abnormal eye movement, irritability, and inability to stand. She had intermittent to-and-fro, horizontal oscillations of the eyes (ocular flutter). She also had truncal and limb ataxia and myoclonus in her head and limbs. Brain magnetic resonance imaging (MRI) showed T1-low and T2-high bulbopontine and cerebellar lesions around the fourth ventricle (Figure). Peripheral blood showed a mild leukocytosis (13.13 × 109/L) and a C-reactive protein level within reference range (0.9 mg/L). Blood chemistry results were unremarkable. Cerebrospinal fluid (CSF) examination showed mononuclear pleocytosis (74/µL) with normal protein and glucose levels. CA16 was isolated from her stool specimen on day 4 of illness. Based on reverse transcription–PCR, CSF was negative for enterovirus RNA.
Figure

Axial T2-weighted slice of brain by magnetic resonance imaging, showing hyperintensity lesions in the pons and cerebellum around the fourth ventricle.

Axial T2-weighted slice of brain by magnetic resonance imaging, showing hyperintensity lesions in the pons and cerebellum around the fourth ventricle. Without specific treatment, our patient’s fever resolved on day 5 of illness. The myoclonus, ocular flutter, and irritability subsided by day 16, when MRI findings returned to normal. Ataxia disappeared gradually ≈1 month after onset, and no neurologic sequelae occurred. Neutralizing antibody titers against CA16 and EV71 on day 21 of illness were 32 and <8, respectively. Based on the sequence analysis of the partial VP1 region (876 bp), we classified the patient’s CA16 strain phylogenetically as genetic lineage C (). This lineage was identical to lineage 2 (), which became the dominant circulating strain in Asia, including Japan, after the late 1990s (98.2% identical to the 1018T/VNM/05 strain isolated in Vietnam in 2005 [GenBank accession no. AM292441]) (,). The patient’s symptoms of irritability, ataxia, myoclonus, and ocular flutter 3 days after the onset of typical HFMD manifestations, along with CSF mononuclear pleocytosis and the lesions around the fourth ventricle shown on MRI, led to the diagnosis of rhombencephalitis associated with HFMD. Virologic examination, including virus isolation and antibody assay, suggested that HFMD was caused by CA16 but not by EV71, although the possibility that CA16 infection was coincidental to the rhombencephalitis could not be excluded. Although rhombencephalitis can be related to various infectious agents (), HFMD complicated by this condition has been exclusively caused by EV71 (,,). In Japan, CA16 and EV71 are consistently the 2 major causative agents of HFMD (). EV71 infection is much more frequently associated with serious neurologic complications and fatalities than is CA16 (). Since 1997, several HFMD outbreaks with multiple cases of severe neurologic pathologies have occurred in the Asia-Pacific region including Malaysia, Taiwan, and Western Australia (,,). These complications were associated exclusively with EV71. Why rhombencephalitis developed in our patient with CA16-related HFMD is unclear. One possibility is that the CA16 strain might have acquired neurovirulence by genetic recombination with EV71; phylogenetic evidence supports the possible occurrence of intertypic recombination involving EV71 and CA16 (). Through phylogenetic analysis of the VP1 sequences, we classified the CA16 strain isolated from the patient’s stool phylogenetically as genetic lineage C (), a lineage which was identical to lineage 2 (). Genetic recombinations among enteroviruses occur mainly in noncapsid regions (). We did not conduct phylogenetic analysis of the noncapsid regions of the patient’s CA16 strain because sequence data on the regions were very limited. Besides the viral factors, host factors, such as immune status and environmental factors, could confer susceptibility to neurologic complications of enteroviral infections. Rhomobencephalitis associated with HFMD developed in this patient and was caused by CA16. Therefore, neurologic complications, including rhombencephalitis, should be considered even when CA16 is the prevalent virus causing HFMD.
  9 in total

1.  Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China.

Authors:  Linlin Li; Yaqing He; Hong Yang; Junping Zhu; Xingye Xu; Jie Dong; Yafang Zhu; Qi Jin
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

2.  Neurologic complications in children with enterovirus 71 infection.

Authors:  C C Huang; C C Liu; Y C Chang; C Y Chen; S T Wang; T F Yeh
Journal:  N Engl J Med       Date:  1999-09-23       Impact factor: 91.245

3.  Molecular phylogeny of modern coxsackievirus A16.

Authors:  D Perera; M A Yusof; Y Podin; M H Ooi; N T T Thao; K K Wong; A Zaki; K B Chua; Y A Malik; P V Tu; N T K Tien; P Puthavathana; P C McMinn; M J Cardosa
Journal:  Arch Virol       Date:  2007-02-19       Impact factor: 2.574

4.  Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group.

Authors:  L G Chan; U D Parashar; M S Lye; F G Ong; S R Zaki; J P Alexander; K K Ho; L L Han; M A Pallansch; A B Suleiman; M Jegathesan; L J Anderson
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

5.  Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998.

Authors:  L Y Chang; T Y Lin; Y C Huang; K C Tsao; S R Shih; M L Kuo; H C Ning; P W Chung; C M Kang
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

6.  Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia.

Authors:  P McMinn; I Stratov; L Nagarajan; S Davis
Journal:  Clin Infect Dis       Date:  2000-12-28       Impact factor: 9.079

7.  Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003.

Authors:  Mitsuaki Hosoya; Yukihiko Kawasaki; Masatoki Sato; Ken Honzumi; Akio Hayashi; Toyomasa Hiroshima; Hiroaki Ishiko; Kazuo Kato; Hitoshi Suzuki
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948

Review 8.  Infectious lesions of the brain stem.

Authors:  W A Hall
Journal:  Neurosurg Clin N Am       Date:  1993-07       Impact factor: 2.509

9.  Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes.

Authors:  Chan Yoke-Fun; Sazaly AbuBakar
Journal:  BMC Microbiol       Date:  2006-08-30       Impact factor: 3.605

  9 in total
  25 in total

Review 1.  Rhombencephalitis / brainstem encephalitis.

Authors:  Burk Jubelt; Cornelia Mihai; Terrence M Li; Padma Veerapaneni
Journal:  Curr Neurol Neurosci Rep       Date:  2011-12       Impact factor: 5.081

2.  Pre-vaccination evolution of antibodies among infants 0, 3 and 6months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16.

Authors:  Chuanxi Fu; Jichuan Shen; Long Lu; Yajing Li; Yimin Cao; Ming Wang; Sen Pei; Zhicong Yang; Qing Guo; Jeffrey Shaman
Journal:  Vaccine       Date:  2017-06-10       Impact factor: 3.641

Review 3.  Acute Flaccid Paralysis and Enteroviral Infections.

Authors:  Ari Bitnun; E Ann Yeh
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

4.  Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment.

Authors:  Matthew N DeSalvo
Journal:  J Radiol Case Rep       Date:  2012-07-01

5.  A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71.

Authors:  Cheng-Hung Yang; Chung-Tiang Liang; Si-Tse Jiang; Kuan-Hsing Chen; Chun-Chiao Yang; Mei-Ling Cheng; Hung-Yao Ho
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

6.  A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Authors:  Ruixiao Du; Qunying Mao; Yalin Hu; Shuhui Lang; Shiyang Sun; Kelei Li; Fan Gao; Lianlian Bian; Ce Yang; Bopei Cui; Longfa Xu; Tong Cheng; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

7.  Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.

Authors:  Shiyang Sun; Liping Jiang; Zhenglun Liang; Qunying Mao; Weiheng Su; Huafei Zhang; Xiaojun Li; Jun Jin; Lin Xu; Dandan Zhao; Peihu Fan; Dong An; Ping Yang; Jingcai Lu; Xiuping Lv; Bo Sun; Fei Xu; Wei Kong; Chunlai Jiang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

8.  A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine.

Authors:  Bopei Cui; Fang Cai; Fan Gao; Lianlian Bian; Ruixia Wu; Ruixiao Du; Xing Wu; Pei Liu; Lifang Song; Lisha Cui; Yadi Yuan; Siyuan Liu; Xiangzhong Ye; Tong Cheng; Qunying Mao; Qiang Gao; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2020-08-04       Impact factor: 3.452

Review 9.  Coxsackievirus A16: epidemiology, diagnosis, and vaccine.

Authors:  Qunying Mao; Yiping Wang; Xin Yao; Lianlian Bian; Xing Wu; Miao Xu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

10.  Development and characterization of a clinical strain of Coxsackievirus A16 and an eGFP infectious clone.

Authors:  Chenglin Deng; Xiaodan Li; Siqing Liu; Linlin Xu; Hanqing Ye; Cheng-Feng Qin; Bo Zhang
Journal:  Virol Sin       Date:  2015-07-24       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.